The Addition Of The MTORr Inhibitor, Everolimus, To Consolidation Therapy In Acute Myeloid Leukaemia: Experience From The UK NCRI AML17 Trial

Burnett, AK; Das Gupta, E; Knapper, S; Khwaja, A; Sweeney, M; Kjeldsen, L; Hawkins, T; ... Russell, NH; + view all Burnett, AK; Das Gupta, E; Knapper, S; Khwaja, A; Sweeney, M; Kjeldsen, L; Hawkins, T; Betteridge, SE; Cahalin, P; Clark, RE; Hills, RK; Russell, NH; - view fewer (2018) The Addition Of The MTORr Inhibitor, Everolimus, To Consolidation Therapy In Acute Myeloid Leukaemia: Experience From The UK NCRI AML17 Trial. Haematologica 10.3324/haematol.2018.189514 . (In press). Green open access

https://ift.tt/2N3xJWn